Vimseltinib Suppliers & Bulk Manufacturers

Available Forms: Capsules

Available Strengths: 14 mg; 20 mg; 30 mg

Reference Brands: Romvimza

Category: Oncology Cancer Care

Vimseltinib is available in Capsules and strengths such as 14 mg; 20 mg; 30 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Vimseltinib is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Vimseltinib can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

Vimseltinib, an investigational oncology drug, is regulated in the EU and US, supported by dossiers demonstrating safety, efficacy, and manufacturing quality according to GMP standards. In the US, regulatory review involves validation, safety assessments, and clinical trial data submission. In the EU, approval processes include validation, stability testing, and conformity with MDR standards. These dossiers encompass safety profiles, clinical trial results, and manufacturing practices. For licensing procedures, approved dossiers, and the latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to innovative therapies that support cancer treatment, advancing patient care and clinical outcomes globally.